Sempra (SRE)

Total Liabilities

$71.98B

Quarterly · Period ending: · USD

SRE logo

SRE Total Liabilities

Latest reported$71.98B
SRE Quarterly Total Liabilities ($2.99B → $71.98B)
High-resolution chart · PNG

SRE total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Sempra Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
71,975,000,000
70,790,000,000
68,879,000,000
66,700,000,000
61,611,000,000
60,808,000,000
58,367,000,000
57,868,000,000
55,054,000,000
54,943,000,000
53,527,000,000
52,477,000,000
51,713,000,000
50,304,000,000
49,318,000,000
46,274,000,000
46,529,000,000
47,362,000,000
44,626,000,000
45,868,000,000
42,916,000,000
42,213,000,000
41,689,000,000
42,366,000,000
42,999,000,000
46,178,000,000
43,860,000,000
44,034,000,000
43,293,000,000
42,148,000,000
41,390,000,000
41,494,000,000
41,543,000,000
42,180,000,000
35,314,000,000
34,627,000,000
33,771,000,000
32,715,000,000
32,545,000,000
32,335,000,000
30,312,000,000
29,111,000,000
28,571,000,000
28,170,000,000
27,531,000,000
27,270,000,000
27,551,000,000
26,825,000,000
26,256,000,000
25,595,000,000
25,394,000,000
25,147,000,000
25,393,000,000
25,933,000,000
25,737,000,000
24,815,000,000
23,909,000,000
23,675,000,000
22,992,000,000
22,632,000,000
21,864,000,000
21,293,000,000
21,045,000,000
19,942,000,000
19,676,000,000
19,477,000,000
19,261,000,000
19,412,000,000
19,190,000,000
18,821,000,000
18,012,000,000
15,747,000,000
15,863,000,000
21,126,000,000
20,051,000,000
21,057,000,000
20,312,000,000
20,315,000,000
21,438,000,000
21,570,000,000
20,460,000,000
21,567,000,000
23,053,000,000
23,102,000,000
18,558,000,000
18,629,000,000
18,910,000,000
18,083,000,000
17,892,000,000
17,320,000,000
18,098,000,000
14,844,000,000
14,992,000,000
16,044,000,000
17,217,000,000
14,246,000,000
14,219,000,000
14,376,000,000
12,188,000,000
12,222,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.